Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Anebulo Pharmaceuticals, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 600K | Oct 6, 2023 | Direct | ||
TYME TECHNOLOGIES, INC. | Chief Executive Officer | Employee Stock Option - Option to buy | 0 | Sep 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ANEB | Anebulo Pharmaceuticals, Inc. | Oct 6, 2023 | 1 | $0 | 4 | Oct 11, 2023 | Chief Executive Officer, Director |
ANEB | Anebulo Pharmaceuticals, Inc. | Oct 6, 2023 | 0 | $0 | 3 | Oct 11, 2023 | Chief Executive Officer, Director |
TYME | TYME TECHNOLOGIES, INC. | Sep 16, 2022 | 3 | $0 | 4 | Sep 16, 2022 | Chief Executive Officer |
TYME | TYME TECHNOLOGIES, INC. | Apr 25, 2022 | 1 | $0 | 4 | Apr 26, 2022 | Chief Executive Officer |
TYME | TYME TECHNOLOGIES, INC. | Jun 14, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Chief Executive Officer |